Medtronic will acquire HeartWare International for $1.1 billion, paying $58 per share in cash, according to The Wall Street Journal.
Supply Chain
In an effort to improve quality control, reduce risk and significantly decrease costs, an increasing number of large hospitals and health networks are launching full-fledged self-distribution programs. Recently, we learned Michigan based Trinity Health is among the latest going self-distributed…
Hijack attacks on medical devices are on the rise, according to a study released Monday by security firm TrapX.
The Food and Drug Administration recently approved Accuray Inc.'s Radixact Treatment Delivery Platform.
The FDA has granted Breakthrough Therapy Designation to Opdivo, a drug from New York City-based drug developer Bristol-Myers Squibb that potentially treats bladder cancer.
Advertisement
An experimental cannabis-based epilepsy drug developed by GW Pharmaceuticals proved effective at reducing the frequency of seizures in a late-stage study, according to Reuters.
A study on Allergy Therapeutics' new hay fever treatment failed to find a recommended dose for a late-stage trial, a setback that will postpone the drug's U.S. launch by a year, according to Reuters.
As the healthcare industry sees a continued uptick in IDNs acquiring more hospitals and post-acute care providers like nursing facilities and ambulatory care sites, it’s no secret that healthcare supply chains are getting larger and more complex – leading to…
The Food and Drug Administration issued a safety advisory on Haemonetics' Leukotrap RC System, warning that faulty filters in some of the recently distributed devices can result in high leukocyte counts in blood used for transfusions.
Britain's decision to leave the European Union is causing regulatory uncertainty for drug companies as the London-based European Medicines Agency — equivalent to the U.S.' Food and Drug Administration — will have to relocate to a city in the EU,…